510(k) K113377
K113377 is an FDA 510(k) premarket notification submitted by Grifols USA, LLC for the device "GLIADIN IGA AND GLIADIN LGA". The FDA issued a decision of Substantially Equivalent on December 14, 2012. The device falls under product code MST (Antibodies, Gliadin), a Class II device regulated under 21 CFR 866.5750. Grifols USA, LLC has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 14, 2012
- Date Received
- November 16, 2011
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antibodies, Gliadin
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type